PCRB vs. IBCA
PCRB (Putnam ESG Core Bond ETF -) and IBCA (iShares iBonds Dec 2035 Term Corporate ETF) are both Intermediate Core Bond funds. PCRB is actively managed, while IBCA is passively managed. Over the past year, PCRB returned 4.53% vs 6.55% for IBCA. Their correlation of 0.87 suggests significant overlap in exposure. PCRB charges 0.35%/yr vs 0.10%/yr for IBCA.
Performance
PCRB vs. IBCA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PCRB achieves a -0.32% return, which is significantly lower than IBCA's 0.20% return.
PCRB
- 1D
- -0.13%
- 1M
- -0.22%
- YTD
- -0.32%
- 6M
- -0.43%
- 1Y
- 4.53%
- 3Y*
- 4.09%
- 5Y*
- —
- 10Y*
- —
IBCA
- 1D
- -0.27%
- 1M
- 0.37%
- YTD
- 0.20%
- 6M
- 0.04%
- 1Y
- 6.55%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PCRB vs. IBCA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PCRB Putnam ESG Core Bond ETF - | -0.32% | 5.02% |
IBCA iShares iBonds Dec 2035 Term Corporate ETF | 0.20% | 7.15% |
Correlation
The correlation between PCRB and IBCA is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.90 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 2025 | 0.87 |
The correlation between PCRB and IBCA has been stable across timeframes, ranging from 0.87 to 0.90 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PCRB vs. IBCA — Risk / Return Rank
PCRB
IBCA
PCRB vs. IBCA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Putnam ESG Core Bond ETF - (PCRB) and iShares iBonds Dec 2035 Term Corporate ETF (IBCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PCRB | IBCA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.13 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.23 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.51 | 2.07 | -0.56 |
| Martin ratioReturn relative to average drawdown | 4.90 | 6.57 | -1.66 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PCRB | IBCA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.21 | 1.33 | -0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 1.08 | -0.49 |
Drawdowns
PCRB vs. IBCA - Drawdown Comparison
The maximum PCRB drawdown since its inception was -7.20%, which is greater than IBCA's maximum drawdown of -3.48%. Use the drawdown chart below to compare losses from any high point for PCRB and IBCA.
Loading charts...
Drawdown Indicators
| PCRB | IBCA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -7.20% | -3.48% | -3.72% |
Max Drawdown (1Y)Largest decline over 1 year | -3.02% | -3.19% | +0.17% |
Max Drawdown (3Y)Largest decline over 3 years | -5.85% | — | — |
Current DrawdownCurrent decline from peak | -2.18% | -1.42% | -0.76% |
Average DrawdownAverage peak-to-trough decline | -1.64% | -0.81% | -0.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.93% | 1.00% | -0.07% |
Volatility
PCRB vs. IBCA - Volatility Comparison
The current volatility for Putnam ESG Core Bond ETF - (PCRB) is 1.32%, while iShares iBonds Dec 2035 Term Corporate ETF (IBCA) has a volatility of 1.62%. This indicates that PCRB experiences smaller price fluctuations and is considered to be less risky than IBCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PCRB | IBCA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.32% | 1.62% | -0.30% |
Volatility (6M)Calculated over the trailing 6-month period | 2.66% | 3.62% | -0.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 3.77% | 4.96% | -1.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 5.63% | 5.76% | -0.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 5.63% | 5.76% | -0.13% |
PCRB vs. IBCA - Expense Ratio Comparison
PCRB has a 0.35% expense ratio, which is higher than IBCA's 0.10% expense ratio.
Dividends
PCRB vs. IBCA - Dividend Comparison
PCRB's dividend yield for the trailing twelve months is around 9.79%, more than IBCA's 4.67% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
IBCA iShares iBonds Dec 2035 Term Corporate ETF | 4.67% | 3.19% | 0.00% | 0.00% |
PCRB Putnam ESG Core Bond ETF - | 9.79% | 4.30% | 4.38% | 3.65% |
Frequently Asked Questions
PCRB and IBCA have a correlation of 0.90, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBCA has higher volatility (1.62%) compared to PCRB (1.32%). In terms of maximum drawdown, PCRB dropped -7.20% vs IBCA's -3.48%.
On 1-year performance, IBCA leads with 6.55% vs 4.53% for PCRB. On fees, IBCA is cheaper at 0.10% per year. On volatility, PCRB has been the lower-risk option at 1.32%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IBCA has performed better with a 6.55% return vs 4.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBCA is cheaper with a 0.10% expense ratio, compared with 0.35% for PCRB.
PCRB has the higher dividend yield at 9.79%, compared with 4.67% for IBCA.
They also come from different issuers: Putnam and iShares. Their fees differ too: 0.35% for PCRB and 0.10% for IBCA.
IBCA currently has the higher Sharpe Ratio (1.33 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PCRB and IBCA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer